1. Home
  2. SOS vs TNON Comparison

SOS vs TNON Comparison

Compare SOS & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOS Limited

SOS

SOS Limited

HOLD

Current Price

$1.39

Market Cap

10.7M

Sector

Finance

ML Signal

HOLD

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$1.12

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOS
TNON
Founded
2004
2012
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
12.8M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
SOS
TNON
Price
$1.39
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
43.6K
107.4K
Earning Date
09-26-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$260,505,000.00
$3,233,000.00
Revenue This Year
N/A
$19.56
Revenue Next Year
N/A
$71.06
P/E Ratio
N/A
N/A
Revenue Growth
134.43
N/A
52 Week Low
$1.02
$0.85
52 Week High
$9.62
$5.85

Technical Indicators

Market Signals
Indicator
SOS
TNON
Relative Strength Index (RSI) 50.59 46.25
Support Level $1.29 $1.11
Resistance Level $1.56 $1.17
Average True Range (ATR) 0.11 0.04
MACD 0.04 0.00
Stochastic Oscillator 65.56 47.09

Price Performance

Historical Comparison
SOS
TNON

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: